Editing policy to fit the genome? R Isasi, E Kleiderman, BM Knoppers Science 351 (6271), 337-339, 2016 | 133 | 2016 |
Global public perceptions of genomic data sharing: what shapes the willingness to donate DNA and health data? A Middleton, R Milne, MA Almarri, S Anwer, J Atutornu, EE Baranova, ... The American Journal of Human Genetics 107 (4), 743-752, 2020 | 112 | 2020 |
Returning incidental findings from genetic research to children: views of parents of children affected by rare diseases E Kleiderman, BM Knoppers, CV Fernandez, KM Boycott, G Ouellette, ... Journal of Medical Ethics 40 (10), 691-696, 2014 | 102 | 2014 |
Trust in genomic data sharing among members of the general public in the UK, USA, Canada and Australia R Milne, KI Morley, H Howard, E Niemiec, D Nicol, C Critchley, ... Human genetics 138, 1237-1246, 2019 | 85 | 2019 |
Attitudes of publics who are unwilling to donate DNA data for research A Middleton, R Milne, A Thorogood, E Kleiderman, E Niemiec, ... European journal of medical genetics 62 (5), 316-323, 2019 | 66 | 2019 |
APPLaUD: access for patients and participants to individual level uninterpreted genomic data A Thorogood, J Bobe, B Prainsack, A Middleton, E Scott, S Nelson, ... Human genomics 12, 1-6, 2018 | 53 | 2018 |
Demonstrating trustworthiness when collecting and sharing genomic data: public views across 22 countries R Milne, KI Morley, MA Almarri, S Anwer, J Atutornu, EE Baranova, ... Genome medicine 13 (1), 92, 2021 | 47 | 2021 |
The ‘serious’ factor in germline modification E Kleiderman, V Ravitsky, BM Knoppers Journal of Medical Ethics 45 (8), 508-513, 2019 | 38 | 2019 |
Members of the public in the USA, UK, Canada and Australia expressing genetic exceptionalism say they are more willing to donate genomic data A Middleton, R Milne, H Howard, E Niemiec, L Robarts, C Critchley, ... European Journal of Human Genetics 28 (4), 424-434, 2020 | 32 | 2020 |
‘Your DNA, Your Say’: global survey gathering attitudes toward genomics: design, delivery and methods A Middleton, E Niemiec, B Prainsack, J Bobe, L Farley, C Steed, J Smith, ... Personalized medicine 15 (04), 311-318, 2018 | 31 | 2018 |
Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials E Kleiderman, A Boily, C Hasilo, BM Knoppers Stem cell research & therapy 9, 1-9, 2018 | 28 | 2018 |
Disease resistance and the definition of genetic enhancement D So, E Kleiderman, SB Touré, Y Joly Frontiers in Genetics 8, 40, 2017 | 27 | 2017 |
Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic D Nicol, L Eckstein, M Morrison, JS Sherkow, M Otlowski, T Whitton, ... Genome medicine 9, 1-4, 2017 | 26 | 2017 |
Heritable genome editing: who speaks for “future” children? BM Knoppers, E Kleiderman The CRISPR journal 2 (5), 285-292, 2019 | 23 | 2019 |
Human gene editing: revisiting Canadian policy BM Knoppers, R Isasi, T Caulfield, E Kleiderman, P Bedford, J Illes, ... NPJ Regenerative Medicine 2 (1), 3, 2017 | 22 | 2017 |
Recruiting terminally ill patients into non-therapeutic oncology studies: views of health professionals E Kleiderman, D Avard, L Black, Z Diaz, C Rousseau, BM Knoppers BMC medical ethics 13, 1-12, 2012 | 21 | 2012 |
Disclosure of incidental findings in cancer genomic research: investigators' perceptions on obligations and barriers E Kleiderman, D Avard, A Besso, S Ali‐Khan, G Sauvageau, J Hebert Clinical genetics 88 (4), 320-326, 2015 | 20 | 2015 |
Realigning gene editing with clinical research ethics: what the “CRISPR Twins” debacle means for Chinese and international research ethics governance E Kleiderman, U Ogbogu Accountability in research 26 (4), 257-264, 2019 | 18 | 2019 |
Exploring resources for intrafamilial communication of cancer genetic risk: we still need to talk KA McClellan, E Kleiderman, L Black, K Bouchard, M Dorval, J Simard, ... European Journal of Human Genetics 21 (9), 903-910, 2013 | 18 | 2013 |
“CRISPR babies”: What does this mean for science and Canada? BM Knoppers, E Kleiderman Cmaj 191 (4), E91-E92, 2019 | 16 | 2019 |